Literature DB >> 336551

Antigenic cross-reactivity between Mycobacterium bovis (BCG) and Leishmania donovani.

L L Smrkovski, C L Larson.   

Abstract

Antigenic cross-reactivity was demonstrated between Mycobacterium bovis (BCG) and Leishmania donovani, using delayed hypersensitivity as a criterion.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 336551      PMCID： PMC421271          DOI： 10.1128/iai.18.2.561-562.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  4 in total

1.  [USE OF BCG ANTIGEN IN THE COMPLEMENT FIXATION TEST FOR THE DIAGNOSIS OF VISCERAL LEISHMANIASIS. (PRELIMINARY NOTE)].

Authors:  J W TORREALBA; J CHAVES-TORREALBA
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1964 Sep-Oct       Impact factor: 1.846

2.  A new method for preparing an antigen from Kedrowsky's bacillus for the complement fixation test for kala-azar.

Authors:  K A KHALEQUE
Journal:  J Pathol Bacteriol       Date:  1962-01

3.  Effect of treatment with BCG on the course of visceral leishmaniasis in BALB/c mice.

Authors:  L L Smrkovski; C L Larson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

4.  Post-kala-azar dermal leishmaniasis.

Authors:  T D Majumdar
Journal:  Dermatol Int       Date:  1967 Jul-Sep
  4 in total
  10 in total

1.  Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis.

Authors:  R Kumar; K Pai; K Pathak; S Sundar
Journal:  Clin Diagn Lab Immunol       Date:  2001-11

Review 2.  Laboratory diagnosis of visceral leishmaniasis.

Authors:  Shyam Sundar; M Rai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

3.  Effect of visceral leishmaniasis on congenitally athymic mice.

Authors:  L L Smrkovski; C L Larson; S G Reed
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

4.  Identification of potentially diagnostic Leishmania braziliensis antigens in human cutaneous leishmaniasis by immunoblot analysis.

Authors:  M E Brito; M G Mendonça; Y M Gomes; M L Jardim; F G Abath
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

5.  Leishmania major-like antigen for specific and sensitive serodiagnosis of human and canine visceral leishmaniasis.

Authors:  Rosângela Barbosa-De-Deus; Marcos Luíz Dos Mares-Guia; Adriane Zacarias Nunes; Kátia Morais Costa; Roberto Gonçalves Junqueira; Wilson Mayrink; Odair Genaro; Carlos Alberto Pereira Tavares
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

6.  Comparative studies of Leishmania soluble antigens by crossed-immunoelectrophoresis: demonstration of specific antigens to L. mexicana and L. braziliensis.

Authors:  L L Leon; M van Hoegaerden; B Galvão-Castro
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

7.  Immunoblot analysis of the humoral immune response to Leishmania donovani infantum polypeptides in human visceral leishmaniasis.

Authors:  L Rolland-Burger; X Rolland; C W Grieve; L Monjour
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

8.  Leishmania mexicana in C3H mice: BCG and levamisole treatment of established infections.

Authors:  G F Grimaldi; P L Moriearty; R Hoff
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

9.  Characterization of immunoglobulin G and its subclass response to Indian kala-azar infection before and after chemotherapy.

Authors:  Rajesh Ravindran; Khairul Anam; Bibhas C Bairagi; Bibhuti Saha; Netai Pramanik; Subhasis K Guha; Rama P Goswami; Dwijadas Banerjee; Nahid Ali
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG.

Authors:  M Mahmoodi; A Khamesipour; Y Dowlati; S Rafati; A Z Momeni; M Emamjomeh; H Hejazi; F Modabber
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.